ErnieBilco
2 months ago
*Sponsored
Market Crux Announces TC BioPharm (NASDAQ: TCBP) As Our Next Potential Breakout Idea!
After Fridayβs Profile Moved Approximately 155% Before the
Opening Bell β Our Focus is Now On (TCBP).
And Hereβs Whyβ¦
TC BioPharm (NASDAQ: TCBP) recently announced a special dividend, offering 0.25 ADSs for every 1 ADS held, showcasing its commitment to those who support it.
With fewer than 585K shares outstanding, TC BioPharm (NASDAQ: TCBP) has a low float, increasing its susceptibility to significant fluctuations.
HC Wainwright & Co. has set a $3 target for TC BioPharm (NASDAQ: TCBP), suggesting over 300% upside potential from Fridayβs open.
Consider Adding TC BioPharm (NASDAQ: TCBP) To Your
Radar This Weekβ¦
Dyno89
4 months ago
Confirmed on ST board as well. 582k outstanding.
Will have to keep an eye on the o/s figure for the next week. But this isn't an otc, it's Nasdaq. If it was otc I'd say it's the company playing games. But its not.
So like I said, I can't see it being dilution, especially after the PR this week about $250,000 in "non dilutive" funding secured.
When they added shares before, they PR'd it immediately as share offerings to raise cash for the clinical trials, etc.
Dyno89
4 months ago
Last I remember pre split, I think it was 9 mil. There was a split also a year ago. So the shares have decreased significantly twice in the past year.
Most recent o/s I can find is about 582,000k
https://finance.yahoo.com/news/tcbp-awarded-non-dilutive-funding-143000233.html
Non dilutive $250,000 funding announced this week, so doesn't make sense they'd be diluting a few days later. Who knows. It's hard to find trustworthy info on it. The S****twits board is more active than here, but many manipulative bashers there. I remember post split months back someone saying the a/s was under 5 mil.
Dyno89
4 months ago
It's definitely under 1 million after the last r/s.
Nothing about this stock makes any sense, been in it for almost two years.
Was trading around $5-$7 over a year ago, then got beat down to well under $1. They did a r/s, became even more of a super low float and o/s. Traded around $4 again earlier this year, climbed up to around $6-$7 again recently. Then on nothing but continued good news and progress (plus a blatantly false Twitter post), it gets beat down to $2, then dumps to where we are under $1 again.